← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2014Last known activity
Aug 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 8 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Recent trials (16)
- NCT06331195CollaboratorN/AAug 31, 2024
- NCT07058922Sponsor investigatorEarly Phase 1Jun 1, 2024
- NCT07058922Lead sponsorEarly Phase 1Jun 1, 2024
- NCT06169241Lead sponsorEarly Phase 1Nov 1, 2023
- NCT06169241Reponsible party - principal investigatorEarly Phase 1Nov 1, 2023
- NCT05695937CollaboratorN/AMay 22, 2023
- NCT04946396Lead sponsorN/AAug 31, 2021
- NCT04946396Reponsible party - principal investigatorN/AAug 31, 2021
- NCT03142399Lead sponsorN/AMar 1, 2017
- NCT03142399Reponsible party - principal investigatorN/AMar 1, 2017
- NCT03142399Study directorN/AMar 1, 2017
- NCT02961972Reponsible party - principal investigatorEarly Phase 1Jan 1, 2015
- NCT02961972Lead sponsorEarly Phase 1Jan 1, 2015
- NCT02620995Reponsible party - principal investigatorPhase 4Oct 1, 2014
- NCT02620995Lead sponsorPhase 4Oct 1, 2014
Details
- Founded
- Rio de Janeiro, BR
- Last known activity
- Aug 31, 2024